IRB Barcelona logo

News

Highlighting IRB Barcelona's impact on society

News

DNA lesions. Credit: Petra Korlevic
Scientific - Published in Nature
Unpicking the complexity of DNA mutations
Representatives of investment funds on the signing of the Series A Ona. Francesc Posas, Emilià Pola, Joël Jean-Mairet, Clara Campàs,Salvador Aznar-Benitah, Valerie Vanhooren and Montserrat Vendrell.
Innovation
Ona Therapeutics raises €30M in Series A financing
Community
So far, so close...
Scientific - Published in Nature Medicine
A role of colibactin-producing E. coli in carcinogenesis
Innovation
Iproteos, IRB Barcelona’s spin-off specialised in drugs to treat diseases of the central nervous system, is taken over by Accure Therapeutics
Institutional
Research centres in Catalonia have conducted 20,000 PCR tests to date
Scientific - Published in Nature Biotechnology
An open-access tool to accelerate drug discovery
Immunofluorescence of a mouse mammary gland duct (IRB Barcelona)
Scientific - Published in Science Advances
Identification of a determining factor in luminal cancer cells, that cause the greatest number of breast cancer cases
Tumour heterogeneity: cancer stem cells (green) and differentiated cells (in red). IRB Barcelona.
Scientific - Published in Cell Stem Cell
Biosynthetic capacity: the key to switch-off cancer stem cells

Media Mentions

Blog

Do you want to be informed?

Visit our blog.

IRB Blog